Look AHEAD试验中2型糖尿病成人中重度体力活动时间与4年血糖控制变化的关联
在Look AHEAD试验的2,416名超重/肥胖2型糖尿病成人中,基于第1年或第4年7天腰部佩戴加速度计记录,按中重度体力活动(bMVPA)时间分布分组。第1年HbA1c降低幅度因bMVPA时间组而异(P=0.02),下午组较不活动组降低-0.22%(95%CI -0.39%, -0.06%),降幅比其他组大30-50%;下午组停药或维持/起始降糖药的优势比最高(OR 2.13, 95%CI 1.29, 3.52)。第4年各组HbA1c在第1年至第4年间无显著变化。结论:下午进行bMVPA与血糖控制改善相关,尤其干预最初12个月内;需实验研究检验因果性。
要点
- 第1年HbA1c降低幅度因bMVPA时间组而异(P=0.02),独立于每周bMVPA总量和强度。
- 下午组HbA1c较不活动组降低-0.22%(95%CI -0.39%, -0.06%),降幅比其他组大30-50%。
- 第1年停药或维持/起始降糖药的优势比因bMVPA时间而异(P=0.04),下午组最高(OR 2.13, 95%CI 1.29, 3.52)。
核心结论
- 下午进行bMVPA与糖尿病成人血糖控制改善相关,尤其干预最初12个月内;需实验研究检验因果性。
研究设计与样本
- Look AHEAD试验中2,416名超重/肥胖2型糖尿病成人(57%女性;平均年龄59岁),第1年或第4年有7天腰部佩戴加速度计记录,按第1年bMVPA时间分布分组并在第4年重新分类。
主要发现
- 第1年HbA1c降低幅度因bMVPA时间组而异(P=0.02),独立于每周bMVPA总量和强度。
- 下午组HbA1c较不活动组降低-0.22%(95%CI -0.39%, -0.06%),降幅比其他组大30-50%。
- 第1年停药或维持/起始降糖药的优势比因bMVPA时间而异(P=0.04),下午组最高(OR 2.13, 95%CI 1.29, 3.52)。
- 第4年所有bMVPA时间组第1年至第4年间HbA1c无显著变化。
关键数值与推荐
- bMVPA时间分组定义:≥50%的bMVPA发生在同一时段(早晨、中午、下午或晚上);任何时段bMVPA<50%(混合);每周bMVPA≤1天(不活动)。
- bMVPA暴露定义:每次≥10分钟的bout相关中重度体力活动。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to determine the association of the time-of-day of bout-related moderate-to-vigorous physical activity (bMVPA) with changes in glycemic control across 4 years in adults with overweight/obesity and type 2 diabetes. RESEARCH DESIGN AND METHODS: Among 2,416 participants (57% women; mean age, 59 years) with 7-day waist-worn accelerometry recording at year 1 or 4, we assigned bMVPA timing groups based on the participants' temporal distribution of bMVPA at year 1 and recategorized them at year 4. The time-varying exposure of bMVPA (≥10-min bout) timing was defined as ≥50% of bMVPA occurring during the same time period (morning, midday, afternoon, or evening), <50% of bMVPA in any time period (mixed), and ≤1 day with bMVPA per week (inactive). RESULTS: HbA1c reduction at year 1 varied among bMVPA timing groups (P = 0.02), independent of weekly bMVPA volume and intensity. The afternoon group had the greatest HbA1c reduction versus inactive (-0.22% [95%CI -0.39%, -0.06%]), the magnitude of which was 30-50% larger than the other groups. The odds of discontinuation versus maintaining or initiating glucose-lowering medications at year 1 differed by bMVPA timing (P = 0.04). The afternoon group had the highest odds (odds ratio 2.13 [95% CI 1.29, 3.52]). For all the year-4 bMVPA timing groups, there were no significant changes in HbA1c between year 1 and 4. CONCLUSIONS: bMVPA performed in the afternoon is associated with improvements in glycemic control in adults with diabetes, especially within the initial 12 months of an intervention. Experimental studies are needed to examine causality.
引用
- Qian J, Xiao Q, Walkup MP, et al. Association of Timing of Moderate-to-Vigorous Physical Activity With Changes in Glycemic Control Over 4 Years in Adults With Type 2 Diabetes From the Look AHEAD Trial. Diabetes Care. 2023. PMID: 37226675. doi:10.2337/dc22-2413
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。